Skip to search formSkip to main contentSkip to account menu

ML 236B

Known as: ML 236 B, ML-236B, ML236B 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
By inhibiting the biosynthesis of endogenous cholesterol, the statin drugs lower elevated blood cholesterol levels much more… 
1986
1986
Two active metabolites of ML-236B, 4β, 6α-dihydroxy ML-236B (M3, 2), and 3β-hydroxy ML-236B (M4, 3), were isolated from the urine… 
1986
1986
Approximately 1,600 fungal strains were tested for ability to convert compactin (ML-236B) to ML-236A and Emericella unguis IFO… 
1985
1985
Several fungal strains were found to convert compactin (ML-236B) to 5'-phosphocompactic acid. The product was isolated by solvent… 
1985
1985
The Basidiomycete Schizophyllum commune was found to transform compactin (ML-236B) to 8a-hydroxycompactin. This compound was… 
1984
1983
1983
Three actinomycetes having capability of 3 beta-hydroxylation of ML-236B were isolated from soil samples collected in Australia… 
1982
1982
A fungal metabolite, ML236B (Compactin), isolated from Penicillium citrinum, is a specific inhibitor of 3-hydroxy-3…